MedTrace Logo

Pilot Study for Healing and Safety Outcomes in Gingival Recession

NCT04614350 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-08-24

No results posted yet for this study

Summary

Prospective, randomized, within subjects-controlled design

Conditions

  • Gingival Recession

Interventions

BIOLOGICAL

Markman Biologics Microsurfaced ADM

an ADM which has been scored (microsurfaced)

BIOLOGICAL

AlloDerm

AlloDerm tissue matrix

Sponsors & Collaborators

  • CellTherX

    collaborator INDUSTRY

  • McGuire Institute

    lead INDUSTRY

Principal Investigators

  • Rick Heard, DDS · The McGuire Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-30
Primary Completion
2022-02-25
Completion
2022-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04614350 on ClinicalTrials.gov